Form 8-K - Current report:
SEC Accession No. 0001619856-24-000071
Filing Date
2024-09-03
Accepted
2024-09-03 16:01:18
Documents
13
Period of Report
2024-09-01
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers

Document Format Files

Seq Description Document Type Size
1 8-K crbu-20240901.htm   iXBRL 8-K 27635
  Complete submission text file 0001619856-24-000071.txt   158866

Data Files

Seq Description Document Type Size
2 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT crbu-20240901.xsd EX-101.SCH 1910
3 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT crbu-20240901_lab.xml EX-101.LAB 23449
4 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT crbu-20240901_pre.xml EX-101.PRE 13587
15 EXTRACTED XBRL INSTANCE DOCUMENT crbu-20240901_htm.xml XML 2916
Mailing Address 2929 7TH STREET, SUITE 105 BERKELEY CA 94710
Business Address 2929 7TH STREET, SUITE 105 BERKELEY CA 94710 510-982-6030
Caribou Biosciences, Inc. (Filer) CIK: 0001619856 (see all company filings)

EIN.: 453728228 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-40631 | Film No.: 241273925
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)